(Reuters) - Activist investor Starboard Value LP, which has an economic stake of 9.8 percent in Depomed Inc , in a letter criticized the drugmaker's board over corporate governance deficiencies and other matters and urged it to explore a potential sale.
Read more
No comments:
Post a Comment